Table 2.
Baseline characteristics of hypertensive patients n (%)
| Endoscopic resection (n = 53) | Subtotal gastrectomy (n = 244) | Total gastrectomy (n = 54) | P | |
| Male | 36 (67.9) | 153 (62.7) | 41 (75.9) | 0.17 |
| Age at treatment (yr, mean ± SE) | 65.2 ± 8.1 | 65.8 ± 8.5 | 66.3 ± 9.3 | 0.79 |
| Comorbid DM | 5 (9.4) | 46 (18.9) | 13 (24.1) | 0.13 |
| Cardiovascular medication | ||||
| Lipid lowering agent | 8 (15.1) | 52 (21.3) | 13 (24.1) | 0.49 |
| Antithrombotic agent | 22 (41.5) | 93 (38.1) | 22 (40.7) | 0.87 |
| Other | 1 (1.9) | 5 (2.0) | 2 (3.7) | 0.85 |
| Antihypertensive agent | ||||
| Calcium channel blocker (C) | 41 (77.4) | 166 (68.0) | 33 (61.1) | 0.19 |
| Diuretics (D) | 19 (35.8) | 92 (37.7) | 21 (38.9) | 0.95 |
| Beta-blocker (B) | 19 (35.8) | 76 (31.1) | 17 (31.5) | 0.80 |
| ACEi or ARB (A) | 15 (28.3) | 82 (33.6) | 18 (33.3) | 0.75 |
| Combination (A, D) | 9 (17.0) | 41 (16.8) | 5 (9.3) | 0.37 |
| Combination (B, D) | 0 (0.0) | 9 (3.7) | 1 (1.9) | 0.54 |
| Combination (A, C) | 0 (0.0) | 6 (2.5) | 3 (5.6) | 0.19 |
| Antihypertensive medications (n) | ||||
| 1 | 18 (33.3) | 73 (29.9) | 16 (30.2) | 0.70 |
| 2 | 25 (46.3) | 97 (39.8) | 22 (41.5) | |
| ≥ 3 | 11 (20.4) | 74 (30.3) | 15 (28.3) | |
ACEi: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin receptor blocker; DM: Diabetes mellitus.